According to a Bloomberg Gadfly article, Johnson & Johnson not only announced its fourth quarter numbers this week, but also its M&A intentions for the year.
CEO Alex Gorsky noted a preference for smaller, more straightforward buys in both pharma and devices, but said that a big deal isn't off the table provided the right opportunity comes along.
J&J is said to have about $39B in cash and short-term investments and expects half of its growth to come from mergers and acquisitions, the article said.
The drugmaker's medical devices business is one potential candidate for the chopping block. Last week, J&J announced plans to cut about 3,000 jobs from the struggling devices business.
Read the full story